GlaxoSmithKline plc (GLAXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:14AM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 76.13B |
| Enterprise value | 94.12B |
| Trailing P/E | 9.77 |
| Forward P/E | 9.19 |
| PEG ratio (5-yr expected) | 0.97 |
| Price/sales (ttm) | 2.00 |
| Price/book (mrq) | 4.54 |
| Enterprise value/revenue | 3.17 |
| Enterprise value/EBITDA | 9.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.27 |
| 52-week change 3 | -2.39% |
| S&P500 52-week change 3 | 15.95% |
| 52-week high 3 | 19.60 |
| 52-week low 3 | 16.34 |
| 50-day moving average 3 | 17.76 |
| 200-day moving average 3 | 17.67 |
Share statistics
| Avg vol (3-month) 3 | 1.51k |
| Avg vol (10-day) 3 | 1.13k |
| Shares outstanding 5 | 4.12B |
| Implied shares outstanding 6 | 4.11B |
| Float 8 | 3.93B |
| % held by insiders 1 | 1.74% |
| % held by institutions 1 | 45.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.7 |
| Forward annual dividend yield 4 | 3.78% |
| Trailing annual dividend rate 3 | 0.56 |
| Trailing annual dividend yield 3 | 3.03% |
| 5-year average dividend yield 4 | 5.13 |
| Payout ratio 4 | 37.47% |
| Dividend date 3 | 09 Jan 2019 |
| Ex-dividend date 4 | 15 Nov 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 20.48% |
| Operating margin (ttm) | 31.37% |
Management effectiveness
| Return on assets (ttm) | 7.90% |
| Return on equity (ttm) | 61.26% |
Income statement
| Revenue (ttm) | 29.65B |
| Revenue per share (ttm) | 7.33 |
| Quarterly revenue growth (yoy) | 4.10% |
| Gross profit (ttm) | 19.92B |
| EBITDA | 9.19B |
| Net income avi to common (ttm) | 6.08B |
| Diluted EPS (ttm) | 1.88 |
| Quarterly earnings growth (yoy) | -86.50% |
Balance sheet
| Total cash (mrq) | 6.68B |
| Total cash per share (mrq) | 1.65 |
| Total debt (mrq) | 20.84B |
| Total debt/equity (mrq) | 165.16% |
| Current ratio (mrq) | 0.95 |
| Book value per share (mrq) | 3.24 |
Cash flow statement
| Operating cash flow (ttm) | 5.48B |
| Levered free cash flow (ttm) | 1.86B |
© 2023 Yahoo. All rights reserved.